...
首页> 外文期刊>Chemical biology and drug design >Design and Synthesis of Imidazolidine-2,4-Dione Derivatives as Selective Inhibitors by Targeting Protein Tyrosine Phosphatase-1B Over T-Cell Protein Tyrosine Phosphatase
【24h】

Design and Synthesis of Imidazolidine-2,4-Dione Derivatives as Selective Inhibitors by Targeting Protein Tyrosine Phosphatase-1B Over T-Cell Protein Tyrosine Phosphatase

机译:以T细胞蛋白酪氨酸磷酸酶为靶标的蛋白酪氨酸磷酸酶-1B设计和合成咪唑烷-2,4-二酮衍生物作为选择性抑制剂

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Owing to its special role as a negative regulator in both insulin and leptin signaling, protein tyrosine phosphatase- 1B (PTP1B) has drawn considerable attention as a target for treating type 2 diabetes and obesity. It, however, is a great challenge to discover inhibitors specific to each PTP due to the highly homologous. In this study, a series of compounds were discovered to inhibit PTP1B based on imidazolidine-2,4-dione by means of 'core hopping'. A selective PTP1B inhibitor (comp#h) was identified, and molecular dynamics simulation and binding free energy calculation were carried out to propose the most likely binding mode of comp#h with PTP1B. The findings reported here may provide a new strategy in discovering selective and effective inhibitors for treating diabetes.
机译:由于酪氨酸磷酸酶-1B(PTP1B)在胰岛素和瘦素信号转导中起负调控作用,因此作为治疗2型糖尿病和肥胖症的靶点已引起了广泛关注。然而,由于高度同源,发现对每个PTP特异的抑制剂是一个巨大的挑战。在这项研究中,发现了一系列化合物通过“核心跳跃”抑制基于咪唑烷-2,4-二酮的PTP1B。确定了选择性PTP1B抑制剂(comp#h),并进行了分子动力学模拟和结合自由能计算,提出了comp#h与PTP1B最可能的结合方式。此处报道的发现可能为发现选择性和有效的糖尿病治疗抑制剂提供了新的策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号